Jonas Salk
AIDS vaccine work

Beginning in the mid-1980s, Salk engaged in research to develop a vaccine for AIDS. He cofounded The Immune Response Corporation (IRC) with Kevin Kimberlin and patented Remune, an immunologic therapy, but was unable to secure liability insurance for the product. The project was discontinued in 2007, twelve years after Salk's death.
startend:end_checker